Prot# CELC200AUS11: A Prospective, Multi-Center, Randomized, Open-Label Study w/Blinded Raters to Evaluate the Effects of Immediate v. Delayed Switch to Stalevo® on Motor Function & Quality of Life in Ptnts w/Parkinson's Disease w/End-Of-Dose Wearing Off

Project: Research project

Project Details

Effective start/end date2/25/059/11/08


  • PRA Health Sciences (CELC200AUS11)
  • Novartis Pharmaceuticals Corporation (CELC200AUS11)